Hwashin America Plans To Expand Greenville, Alabama, Operations
11/08/2018
Hwashin, a Tier 1 supplier for Hyundai's assembly plant in Montgomery, produces body components for Hyundai’s Alabama auto assembly plant. The operation began in 2003 with a 150,000-square-foot facility and 200 workers. Today, the company’s 650,000-square-foot plant is staffed with more than 750 workers.
“Companies have a choice regarding where they locate and expand. We appreciate the confidence Hwashin has shown in Greenville and Butler County since 2003,” said David Crenshaw, Chairman of the Butler County Commission for Economic Development (BCCED).
To facilitate the company’s latest expansion, the Greenville City Council granted statutory tax abatements at a Nov. 5 meeting. The expansion is projected to boost payroll by $1 million and increase property tax revenue to the Butler County School System by more than $500,000 over 10 years.
“We are excited about the new jobs and investment Hwashin has committed to Greenville,” said Mayor Dexter McLendon. “Great things happen when city and county governments work together toward a common goal.”
Project Announcements
Walmart Upgrades Opelousas, Louisiana, Distribution Operations
01/20/2026
Canada-Based Voltari Marine Electric Plans Bay County, Florida, Operations
01/20/2026
Japan-Based DENSO Expands Lebanon, Tennessee, Logistics Operations
01/20/2026
Infinity Global Expands Danville, Virginia, Headquarters Operations
01/17/2026
Kratos Plans Somerset County, Maryland, Production Operations
01/17/2026
CesiumAstro Expands Bee Cave, Texas, Headquarters-Manufacturing Operations
01/16/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025